XT
NMRA icon

XTX Topco’s Neumora Therapeutics NMRA Stock Holding History

XTX Topco’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184K Sell
108,236
-113,612
-51% -$216K ﹤0.01% 3295
2026
Q1 		$433K Buy
221,848
+107,935
+95% +$280K 0.01% 2173
2025
Q4 		$204K Buy
+113,913
New +$249K 0.01% 2388
2025
Q2 		– Sell
-233,597
Closed -$234K – 2905
2025
Q1 		$234K Buy
233,597
+211,759
+970% +$363K 0.01% 1590
2024
Q4 		$231K Buy
+21,838
New +$262K 0.02% 1440
2024
Q2 		– Sell
-12,352
Closed -$170K – 2279
2024
Q1 		$170K Buy
+12,352
New +$200K 0.02% 1226

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

XTX Topco's NMRA Position: Q2 2026 in Review

XTX Topco reduced its Neumora Therapeutics (NMRA) stake by 51% in Q2 2026, selling an estimated $216K and leaving 108,236 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #3295.

XTX Topco first reported a position in NMRA in Q1 2024 and has held it in 6 quarters since. The position peaked at $433K in Q1 2026. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • XTX Topco held 108,236 shares of Neumora Therapeutics worth $184K as of Q2 2026.
  • XTX Topco sold 113,612 Neumora Therapeutics shares in Q2 2026, an estimated $216K.
  • Neumora Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3295 holding.
  • XTX Topco first reported a position in Neumora Therapeutics in Q1 2024 and has held it in 6 quarters since.
  • XTX Topco's Neumora Therapeutics position peaked at $433K in Q1 2026.
  • 113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.